Zoetis Return on Investment 2012-2025 | ZTS

Current and historical return on investment (ROI) values for Zoetis (ZTS) over the last 10 years.
Zoetis ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2025-09-30 $3.33B $12.47B 31.32%
2025-06-30 $3.32B $10.21B 31.68%
2025-03-31 $3.20B $9.88B 29.59%
2024-12-31 $3.13B $9.99B 27.89%
2024-09-30 $3.05B $11.81B 26.25%
2024-06-30 $2.89B $11.52B 24.99%
2024-03-31 $2.99B $11.61B 25.98%
2023-12-31 $2.94B $11.56B 25.86%
2023-09-30 $2.88B $11.63B 25.69%
2023-06-30 $2.83B $11.18B 26.27%
2023-03-31 $2.63B $11.05B 25.20%
2022-12-31 $2.66B $10.96B 26.22%
2022-09-30 $2.57B $9.87B 25.26%
2022-06-30 $2.56B $9.80B 24.34%
2022-03-31 $2.53B $9.89B 23.39%
2021-12-31 $2.49B $11.14B 22.60%
2021-09-30 $2.40B $11.27B 22.21%
2021-06-30 $2.34B $10.94B 22.18%
2021-03-31 $2.19B $10.68B 21.11%
2020-12-31 $2.00B $10.37B 20.23%
2020-09-30 $2.01B $10.20B 21.33%
2020-06-30 $1.94B $10.18B 21.20%
2020-03-31 $1.92B $8.72B 21.69%
2019-12-31 $1.80B $8.66B 20.35%
2019-09-30 $1.78B $9.13B 20.15%
2019-06-30 $1.67B $8.86B 19.22%
2019-03-31 $1.65B $8.76B 20.12%
2018-12-31 $1.69B $8.63B 21.77%
2018-09-30 $1.70B $8.56B 23.34%
2018-06-30 $1.70B $6.94B 24.62%
2018-03-31 $1.61B $6.93B 24.59%
2017-12-31 $1.53B $6.74B 24.87%
2017-09-30 $1.33B $6.97B 22.33%
2017-06-30 $1.25B $5.47B 21.81%
2017-03-31 $1.23B $5.35B 21.24%
2016-12-31 $1.23B $5.97B 20.89%
2016-09-30 $1.07B $6.07B 18.45%
2016-06-30 $1.01B $5.84B 18.70%
2016-03-31 $0.65B $5.65B 12.86%
2015-12-31 $0.55B $5.55B 11.46%
2015-09-30 $0.63B $4.48B 13.69%
2015-06-30 $0.60B $4.45B 12.56%
2015-03-31 $0.82B $4.55B 16.91%
2014-12-31 $0.82B $4.96B 16.69%
2014-09-30 $0.79B $5.03B 16.39%
2014-06-30 $0.74B $4.93B 15.72%
2014-03-31 $0.73B $4.74B 15.83%
2013-12-31 $0.69B $4.60B 15.39%
2013-09-30 $0.65B $4.51B 14.45%
2013-06-30 $0.67B $4.46B 20.15%
2013-03-31 $0.74B $4.36B 33.16%
2012-12-31 $0.72B $4.55B 63.12%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $55.457B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $88.134B 33.47
Takeda Pharmaceutical (TAK) Japan $52.407B 10.69
Daiichi Sankyo, - (DSNKY) Japan $40.558B 20.20
BeOne Medicines - (ONC) Switzerland $38.026B 201.60
Sandoz Group AG (SDZNY) Switzerland $33.757B 0.00
United Therapeutics (UTHR) United States $20.483B 18.03
Merck (MKKGY) Germany $19.238B 11.86
Shionogi (SGIOY) Japan $15.687B 14.41
Summit Therapeutics (SMMT) United States $13.611B 0.00
Neurocrine Biosciences (NBIX) United States $13.493B 32.38
Ionis Pharmaceuticals (IONS) United States $12.775B 0.00
IPSEN (IPSEY) France $12.596B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.474B 0.00
Orion OYJ (ORINY) Finland $10.204B 29.15
Eisai (ESAIY) $8.539B 0.00
Ono Pharmaceutical (OPHLF) Japan $6.576B 20.00
Grifols, S.A (GRFS) Spain $6.353B 0.00
Stevanato Group S.p.A (STVN) Italy $6.196B 34.68
Crinetics Pharmaceuticals (CRNX) United States $5.259B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.613B 0.00
Indivior (INDV) United States $4.204B 17.16
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.165B 19.78
Corcept Therapeutics (CORT) United States $3.896B 42.09
NewAmsterdam Pharma (NAMS) Netherlands $3.619B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.969B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.848B 9.09
Hypermarcas (HYPMY) Brazil $2.717B 18.65
Dyne Therapeutics (DYN) United States $2.492B 0.00
Ocular Therapeutix (OCUL) United States $2.358B 0.00
Soleno Therapeutics (SLNO) United States $2.281B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.100B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.008B 23.80
Guardian Pharmacy Services (GRDN) United States $1.908B 36.74
Harrow (HROW) United States $1.784B 109.46
Ardelyx (ARDX) United States $1.674B 0.00
Oruka Therapeutics (ORKA) United States $1.549B 0.00
Enliven Therapeutics (ELVN) United States $1.546B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.545B 0.00
Collegium Pharmaceutical (COLL) United States $1.472B 7.29
BioCryst Pharmaceuticals (BCRX) United States $1.429B 84.75
Relay Therapeutics (RLAY) United States $1.399B 0.00
Evotec AG (EVO) Germany $1.314B 0.00
Xeris Biopharma Holdings (XERS) United States $1.258B 0.00
Savara (SVRA) United States $1.221B 0.00
ARS Pharmaceuticals (SPRY) United States $1.165B 0.00
Theravance Biopharma (TBPH) United States $1.044B 43.85
Xencor (XNCR) United States $1.032B 0.00
Cronos Group (CRON) Canada $1.006B 0.00
Esperion Therapeutics (ESPR) United States $0.772B 0.00
KalVista Pharmaceuticals (KALV) United States $0.770B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.739B 17.46
Nektar Therapeutics (NKTR) United States $0.734B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.710B 6.34
ProKidney (PROK) United States $0.686B 0.00
Bioventus (BVS) United States $0.641B 13.12
Lexeo Therapeutics (LXEO) United States $0.563B 0.00
Zevra Therapeutics (ZVRA) United States $0.516B 0.00
Elite Pharmaceuticals (ELTP) United States $0.513B 0.00
4D Molecular Therapeutics (FDMT) United States $0.501B 0.00
Lyell Immunopharma (LYEL) United States $0.498B 0.00
Organogenesis (ORGO) United States $0.491B 0.00
Siga Technologies (SIGA) United States $0.481B 6.59
Altimmune (ALT) United States $0.436B 0.00
Aquestive Therapeutics (AQST) United States $0.429B 0.00
Nature's Sunshine Products (NATR) United States $0.389B 23.18
USANA Health Sciences (USNA) United States $0.374B 10.45
Akebia Therapeutics (AKBA) United States $0.366B 0.00
Avalo Therapeutics (AVTX) United States $0.300B 0.00
Achieve Life Sciences (ACHV) Canada $0.299B 0.00
Aclaris Therapeutics (ACRS) United States $0.297B 0.00
Larimar Therapeutics (LRMR) United States $0.282B 0.00
Relmada Therapeutics (RLMD) United States $0.282B 0.00
Silence Therapeutics (SLN) United Kingdom $0.277B 0.00
Profound Medical (PROF) Canada $0.277B 0.00
Fractyl Health (GUTS) United States $0.275B 0.00
OmniAb (OABI) United States $0.275B 0.00
Heron Therapeutics (HRTX) United States $0.273B 0.00
Aldeyra Therapeutics (ALDX) United States $0.255B 0.00
Protara Therapeutics (TARA) United States $0.255B 0.00
Enlivex Therapeutics (ENLV) Israel $0.229B 0.00
Journey Medical (DERM) United States $0.213B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.206B 0.00
Galectin Therapeutics (GALT) United States $0.193B 0.00
MediWound (MDWD) Israel $0.189B 0.00
Minerva Neurosciences (NERV) United States $0.187B 0.00
Innate Pharma SA (IPHYF) France $0.181B 0.00
Century Therapeutics (IPSC) United States $0.177B 0.00
Surrozen (SRZN) United States $0.171B 0.00
AleAnna (ANNA) United States $0.167B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.161B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.145B 0.00
Context Therapeutics (CNTX) United States $0.144B 0.00
Prelude Therapeutics (PRLD) United States $0.142B 0.00
Unicycive Therapeutics (UNCY) United States $0.142B 0.00
Incannex Healthcare (IXHL) Australia $0.135B 0.00
VAXART, INC (VXRT) United States $0.132B 0.00
Karyopharm Therapeutics (KPTI) United States $0.132B 0.00
Inhibikase Therapeutics (IKT) United States $0.128B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.127B 0.00
Pyxis Oncology (PYXS) United States $0.124B 0.00
Avita Medical (RCEL) United States $0.107B 0.00
Cassava Sciences (SAVA) United States $0.104B 0.00
Champions Oncology (CSBR) United States $0.100B 42.24
Cardiol Therapeutics (CRDL) Canada $0.097B 0.00
Vivani Medical (VANI) United States $0.093B 0.00
Korro Bio (KRRO) United States $0.085B 0.00
Gain Therapeutics (GANX) United States $0.085B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.073B 61.00
PolyPid (PYPD) Israel $0.069B 0.00
Dominari Holdings (DOMH) United States $0.069B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Arch Biopartners (ACHFF) Canada $0.066B 0.00
Assertio Holdings (ASRT) United States $0.066B 0.00
Metagenomi (MGX) United States $0.065B 0.00
NRx Pharmaceuticals (NRXP) United States $0.064B 0.00
Lipocine (LPCN) United States $0.061B 0.00
PMV Pharmaceuticals (PMVP) United States $0.061B 0.00
Acrivon Therapeutics (ACRV) United States $0.058B 0.00
Lite Strategy (LITS) United States $0.057B 0.00
ElectroCore (ECOR) United States $0.052B 0.00
Nutriband (NTRB) United States $0.052B 0.00
Talphera (TLPH) United States $0.048B 0.00
Telomir Pharmaceuticals (TELO) United States $0.046B 0.00
Plus Therapeutics (PSTV) United States $0.040B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Kyntra Bio Inc (KYNB) United States $0.038B 0.00
Wellgistics Health (WGRX) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.030B 0.00
Natural Alternatives (NAII) United States $0.029B 0.00
Jupiter Neurosciences (JUNS) United States $0.028B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Klotho Neurosciences (KLTO) United States $0.022B 0.00
Scienture Holdings (SCNX) United States $0.021B 0.00
Inotiv (NOTV) United States $0.021B 0.00
Liminatus Pharma (LIMN) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Iterum Therapeutics (ITRM) Ireland $0.017B 0.00
Vyome Holdings (HIND) United States $0.017B 0.00
Cosmos Health (COSM) United States $0.017B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Traws Pharma (TRAW) United States $0.014B 0.02
Tempest Therapeutics (TPST) United States $0.013B 0.00
CASI Pharmaceuticals (CASI) China $0.013B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.009B 0.00
Ainos (AIMD) United States $0.009B 0.00
BioVie (BIVI) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Heatwurx (PCSA) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
Redhill Biopharma (RDHL) Israel $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Decoy Therapeutics Inc (DCOY) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Lyra Therapeutics (LYRA) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
CDT Equity (CDT) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00